Company Filing History:
Years Active: 2012
Title: A Profile of Inventor Robert Schiffers
Introduction
Robert Schiffers, an innovative inventor based in Gau Algesheim, Germany, has made significant strides in the field of pharmaceutical science. With one patent to his name, Schiffers has contributed to the development of new processes in drug manufacturing, particularly focusing on indolinone derivatives, which hold promise in medicinal chemistry.
Latest Patents
Schiffers' noteworthy patent is titled "Process for the manufacture of an indolinone derivative." This invention encompasses a method for producing a specific indolinone derivative and its pharmaceutically acceptable salt, specifically 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and its monoethanesulfonate. The patent also introduces new manufacturing steps and intermediates, enhancing overall efficiency in drug production.
Career Highlights
Robert Schiffers is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at Boehringer Ingelheim has allowed him to collaborate with experts in the industry and participate in innovative projects that push the boundaries of pharmaceutical development.
Collaborations
During his career, Schiffers has collaborated with several notable colleagues, including Joern Merten and Guenter Linz. These collaborations have fostered an environment of shared knowledge and innovation, further driving advancements in their projects and research within the pharmaceutical sector.
Conclusion
In summary, Robert Schiffers stands out as a dedicated inventor whose work in the pharmaceutical field has the potential to significantly impact drug development. His patent focusing on indolinone derivatives underlines his expertise and contribution to advancements in medicinal chemistry. As he continues his work at Boehringer Ingelheim, Schiffers is poised to remain a key figure in the evolution of innovative pharmaceutical processes.